Leica BOND Ready-to-Use Primary Antibody Immunochemistry Antibody (Other Cancer Markers)
- Device Class
- CLASS B IVD
- Medical Speciality Area
- Immunology
- Registration Number
- DE0510441
- Registration Date
- March 08, 2025
- Retention Due Date
- March 07, 2026
- Short Name
- Leica Biosystems Newcastle Ltd
- Address
- Balliol Business Park West, Benton Lane, Newcastle upon Tyne NE12 8EW, UNITED KINGDOM
- Address
- 15 TUKANG INNOVATION DRIVE, SINGAPORE 618299
- Address
- 18 BOON LAY WAY, TRADEHUB 21, #05-105, SINGAPORE 609966 15 TUKANG INNOVATION DRIVE, SINGAPORE 618299
- Model Name(s)
- MLH1 (Mismatch Repair Protein) MSH2 (Mismatch Repair Protein) MSH6 (Mismatch Repair Protein) PMS2 (Mismatch Repair Protein)
- Model Identifier(s)
- PA0988 PA0989 PA0990 PA0991
Access comprehensive regulatory information for Leica BOND Ready-to-Use Primary Antibody Immunochemistry Antibody (Other Cancer Markers) in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0510441 and owned by Leica Biosystems Newcastle Ltd. The device was registered on March 08, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.